TY  - JOUR
AU  - Longo, Federico
AU  - Jorge, Mónica
AU  - Yaya, Ricardo
AU  - Montes, Ana Fernández
AU  - Lago, Nieves Martínez
AU  - Brozos, Elena
AU  - Aparicio, Jorge
AU  - Quintero, Guillermo
AU  - Ceballos, Eduardo
AU  - Buxó, Elvira
AU  - Lopez, Ana Maria
AU  - Pellón, Maria Luz
AU  - Molina, Raquel
AU  - Diaz-Paniagua, Laura
AU  - Cerdà, Paula
AU  - Leiva, Pedro Lopez
AU  - Carnicero, Alfonso Martín
AU  - Cousillas, Antía
AU  - Paris, Lorena
AU  - García-Paredes, Beatriz
AU  - Romero, Carlos
AU  - Ortega, María
AU  - Molero, Alberto
AU  - la Torre, Sergio de
AU  - Jen, Min-Hua
AU  - Díaz-Cerezo, Silvia
PY  - 2021
DO  - 10.2217/fon-2020-1216
UR  - http://hdl.handle.net/10668/17186
T2  - Future oncology (London, England)
AB  - Aims: To obtain real-world data on ramucirumab use and effectiveness for the treatment of advanced gastric cancer (AGC) or gastroesophageal junction adenocarcinoma (GEJ). Methods: Observational, retrospective study carried out in 20 Spanish hospitals,...
LA  - en
KW  - effectiveness
KW  - gastric cancer/GEJ adenocarcinoma
KW  - ramucirumab
KW  - real-world data
KW  - treatment patterns
KW  - Adenocarcinoma
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - Chemotherapy, Adjuvant
KW  - Esophagogastric Junction
KW  - Female
KW  - Gastrectomy
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Paclitaxel
KW  - Progression-Free Survival
KW  - Retrospective Studies
KW  - Spain
KW  - Stomach Neoplasms
TI  - Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS study.
TY  - research article
VL  - 17
ER  -